90 results
Page 2 of 5
8-K
EX-10.1
30z2iwvzz giypx5w
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
8-K
EX-99.1
tbz540
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
8-K
xptr8o
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
f9hzox0 m8zv
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
6g0xa
20 Dec 22
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
8m1v8o9k amwch8j5av5
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
sg529gjlx ncg
28 Apr 22
Prospectus supplement for primary offering
8:09am